These findings substantiate the importance of GR in the pathogenesis of insulin resistance and obesity and thereby implicate the GR as a potential target for the treatment of Type 2 diabetes and obesity. This evidence concerns the gene NR3C1 and obesity due to melanocortin 4 receptor deficiency.